ADBiotech Co., Ltd. (KOSDAQ:179530)

Market Cap	38.54B
Revenue (ttm)	11.66B
Net Income (ttm)	-4.07B
Shares Out	12.59M
EPS (ttm)	-440.11
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	106,168
Average Volume	428,759
Open	2,980.00
Previous Close	3,030.00
Day's Range	2,950.00 - 3,130.00
52-Week Range	1,351.00 - 5,450.00
Beta	1.34
RSI	45.53
Earnings Date	Aug 11, 2025

About ADBiotech

ADBiotech Co., Ltd. develops and sells antibodies for livestock, fisheries, and humans in South Korea and internationally. The company offers antibiotic, disinfectant, helminthic, over the counter drugs, supplementary feed, and metabolic drugs. It also offers health functional and processed foods. ADBiotech Co., Ltd. was founded in 2000 and is based in Chuncheon-si, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2000
• Employees: 59
• Stock Exchange: KOSDAQ
• Ticker Symbol: 179530

Financial Performance

In 2024, ADBiotech's revenue was 11.14 billion, an increase of 6.34% compared to the previous year's 10.47 billion. Losses were -7.95 billion, 177.7% more than in 2023.